Transnational medical travel, often described in both popular news media accounts and scholarly publications as “medical tourism,” involves individuals leaving their local communities and seeking healthcare at international hospitals and clinics. Because it is accessible to prospective customers all over the world, the Internet plays a powerful role in providing an advertising platform for what is now a global market in health services.Footnote 1 Individuals considering paying out of pocket for elective medical procedures can explore the websites of hospitals and medical tourism companies; review lists of procedures as well as additional options such as travel plans, holiday excursions, and hotel accommodations; choose their preferred healthcare packages; and then travel to selected destinations.Footnote 2, Footnote 3 Costa Rica, Cuba, Dominican Republic, India, Mexico, Singapore, and Thailand are countries known for attracting international patients, but it is important to note that many nations around the world are promoting themselves as destinations for medical travelers.Footnote 4 Within many countries, individual medical facilities as well as entire hospital chains run by large healthcare corporations use numerous marketing strategies to attract international patients.Footnote 5 Company websites, brochures, DVDs, YouTube videos, Facebook pages, Twitter, and other media are used to target different customer niches and expand the market for medical travel.Footnote 6 Treatment delays in countries with publicly funded healthcare systems, the escalating cost of out-of-pocket care in settings where not all citizens have publicly funded access to healthcare, interest in accessing interventions unapproved within domestic healthcare contexts, budget air travel, favorable currency exchange rates, the emergence of the Internet as a global marketing platform, and other factors all promote increased movement of patients across borders.Footnote 7
Terminology: “Medical Tourism” or “Medical Travel”?
For some episodes of medical travel, “medical tourism” is a suitable label to describe the phenomenon. Some patients purchase healthcare packages that include stays in expensive hotels or luxurious resorts, access to local drivers, holiday excursions or tours to local attractions, and meals at costly restaurants. Other, more budget-conscious patients travel for affordable healthcare and engage in few activities typically associated with tourism. The appropriateness of the phrase “medical tourism” is a subject of considerable scholarly debate, although in popular news coverage the term is now commonplace. Acknowledging that not all journeys for healthcare involve activities commonly associated with tourism and wanting to avoid such jarring phrases as “suicide tourism” and “transplant tourism,” in this analysis I use the term “transnational medical travel.”Footnote 8 The phrase is intended to describe health-related travel that involves a journey from one nation to another. I use this label because of my concern that the more commonly used label “medical tourism” trivializes various forms of medical care, fails to acknowledge that many health-related journeys do not involve tourism-like activities, and in some instances is offensive to individuals who travel for serious health problems and resent being characterized as tourists simply because they seek healthcare outside their home countries.Footnote 9
Reasons for Transnational Medical Travel
Proponents of expanding global trade in health services provide many reasons why prospective medical travelers should seek healthcare outside their local communities.Footnote 10 They also advance powerful arguments for characterizing healthcare as falling within the scope of goods and services subject to international trade. Advocates of an international marketplace for health services argue that transnational medical travel reduces costs for patients paying out of pocket, expedites access to treatment for patients otherwise compelled to wait for care, enables patients to combine medical care with recovery in comfortable surroundings, allows patients to undergo procedures unapproved within domestic settings, and permits integration of biomedical procedures with indigenous therapies.Footnote 11 They argue that the option of engaging in medical travel promotes choice, frees patients from domestic healthcare providers, and can play an important role in reducing healthcare expenditures for individuals, private health insurers, and public health insurance plans by forcing hospitals and clinics to compete in a global marketplace. In this new transnational space, medical facilities must differentiate themselves from competitors on the basis of inexpensive treatment, high quality of care, timely access to treatment, and other factors. In addition, they claim that by boosting tourism, increasing foreign direct investment and employment in the healthcare and hospitality sectors, and in some instances cross-subsidizing care of domestic patients, global trade in health services promotes economic and social development in such low- and middle-income nations as Malaysia and the Philippines. According to this line of reasoning, global trade in health services offers the same benefits found in international trade of other goods and services. To proponents of global trade in health services, there is nothing distinctive about provision of healthcare that makes it unsuitable for international commercial transactions.
Whatever the general social consequences of the development of a global health services marketplace, having access to a worldwide marketplace benefits some individuals. Numerous patients frustrated with waiting for procedures in their home countries can now travel abroad and return home satisfied with their decision to purchase expedited access to care.Footnote 12 Some individuals travel for stem cell injections, “liberation therapy” for multiple sclerosis, and other interventions that have unknown safety and efficacy profiles and are not approved in their home countries.Footnote 13, Footnote 14 Other patients travel for orthopedic procedures, dental surgery, ophthalmologic procedures, and organ transplants. In some countries, lack of health insurance is a driver of going abroad for healthcare. For example, more than 47 million Americans are without health insurance, and many more U.S. citizens are underinsured.Footnote 15 For some U.S. residents, lack of health insurance combined with the unaffordable cost of care at local institutions means that they must decide whether to purchase access to treatment abroad, go into debt to obtain local care, self-treat, or do without care.Footnote 16 Around the world, individuals with sufficient financial resources travel for care when they cannot obtain treatment at local institutions.Footnote 17, Footnote 18 General motivations for medical travel are by now reasonably well established. Of course, individual reasons for travel vary from patient to patient and depend on individual circumstances and broader social-structural forces that either enable patients to obtain the care they seek in local settings or prompt them to search for care beyond nearby healthcare facilities.
Patient Flows and Clinical Outcomes Data
Business reports and some scholarly articles make dramatic claims about the number of individuals entering the global health services marketplace and engaging in transnational medical travel. Though various figures are now routinely used as “proof” that the international healthcare marketplace is expanding in dramatic fashion, it is important to emphasize that there are no comprehensive global datasets documenting how many patients leave their local communities and receive care at international facilities. In addition, there are no systematic studies addressing how many medical travelers have experienced desired outcomes, treatment-related surgical complications, or hospital-acquired infections as a result of care received abroad. Though anthropologists, geographers, sociologists, and other social scientists are engaged in various qualitative research projects, systematic, quantitative clinical outcomes data are surprisingly sparse. Studying the movement of patients across borders and the effects of medical travel is challenging because medical travelers begin their journeys from many different nations, travel to an equally diverse number of countries, and commonly go abroad without the aid of government ministries or other bodies that might document their travel. In many settings, healthcare provided in domestic contexts is far better documented than care obtained by traveling from one nation to another country. Administrative tracking of medical travelers has not kept pace with the increased global movement of patients.
Recognizing the need for better quantitative and qualitative data concerning clinical outcomes and patient experiences in medical travel, current evidence suggests that numerous features of medical travel raise serious ethical issues and prompt concerns about the adequacy of informed consent, the quality of care and patient safety, medical malpractice and liability, and the effects of medical travel on public health, healthcare systems, and health human resources in the home countries of medical travelers and the nations to which they journey for treatment. These topics deserve careful ethical analysis as patients, health insurance companies, medical tourism companies, and hospital chains all express interest in promoting the globalization of healthcare.
Patient-Physician Communication
Medical tourism companies and international hospitals promote a model of healthcare in which individuals leave their local communities and travel abroad for treatment.Footnote 19 Given that transnational medical travel involves movement to distant healthcare facilities, there often is little opportunity for the preoperative conversations physicians typically have during the process of exploring whether patients should proceed with surgical interventions and other invasive procedures or consider nonsurgical options such as symptom management and physical therapy. In medical travel, patient-physician communication sometimes occurs only after patients have paid for procedures and traveled to destination hospitals. Prior to arrival, facilitators employed by medical tourism companies as well as employees of international destination hospitals often are key providers of information about planned procedures. Whatever benefits tourism facilitators provide by organizing travel and providing information, this arrangement risks limiting opportunities for meaningful patient-physician communication before treatment. It also means that patients receive information from individuals, many of whom appear to lack training in the healthcare professions, who typically have a direct financial interest in ensuring that prospective clients purchase health services.Footnote 20 Such an arrangement prompts questions about how informed medical travelers are when they sign contracts with medical tourism companies or hospitals and subsequently travel for care. Numerous studies examine the quality of information provided by the websites of medical tourism companies.Footnote 21, Footnote 22 These studies consistently report that these websites minimize risks associated with various medical procedures and provide prospective clients with little information about postoperative care and the role of the medical tourism companies in the event of treatment-related complications.
Medical parentalism, the traditional notion that the doctor knows best and that patients are not well positioned to make their own decisions about healthcare, is often identified as a major barrier to adequate disclosure of information to patients and genuine informed choice. In the global marketplace for health services, commercial interests, in which various parties benefit from sale of medical procedures, might pose greater obstacles to informed patient choice than traditional hierarchical models of the patient-physician relationship. The profit-driven ethos of the global health services marketplace appears to play a role in framing how information is provided to patients. If clients of medical tourism companies are given misleading accounts of risks and benefits, it is possible that some medical travelers undergo medical procedures that pose questionable risk-benefit ratios and are not in their best interests. Outcomes in care of some medical travelers prompt questions about clinical judgments concerning whether surgery was warranted, given patient risk factors, the possibility of complications, and alternatives to surgery. Medical tourism companies and private hospitals in destination nations profit from selling health services. They have the same financial interests that drive private, for-profit hospitals and clinics in domestic contexts. However, in the current global marketplace, regulation of medical facilities in numerous domestic contexts is often considerably more rigorous than regulatory standards in leading destination nations. Given that medical tourism companies and destination hospitals benefit from selling services rather than recommending nonsurgical, unprofitable interventions such as better nutrition, more exercise, preventive care, and physical therapy, it is possible that some medical travelers undergo procedures that are not justified by best available evidence.
An additional problem is associated with restricted opportunities for patient-physician communication before surgery. The often brief period between when medical travelers arrive at destination facilities and then undergo treatment means there is little time for clinicians to exercise evidence-based professional judgment and determine whether travelers are suitable candidates for surgery. Teleconferencing, teleradiology, and transmission of electronic medical records can all help promote continuity of care as patients move from domestic healthcare settings to distant international medical facilities. When patient histories, medical records, and prior conversations with healthcare providers are not accessible at international destinations, patients are at risk of receiving care that does not take into account their prior medical history. Unfamiliarity with the medical history of patients can complicate judgments about whether treatment is advisable. In some destination countries, language barriers can also impede communication between medical travelers and treating clinicians.
Quality of Care and Patient Safety
While acknowledging that some patients receive high-quality care at international facilities, numerous case reports reveal that other medical travelers return home with complications requiring costly and long-term treatment. Case reports and surveys of physicians who have treated complications following medical travelers’ return from international facilities reveal that some medical travelers arrive home and require emergency treatment, revision surgery, long-term management of uncommon infections, and extensive rehabilitation.Footnote 23, Footnote 24, Footnote 25 Newspaper reports identify patients who traveled for elective cosmetic surgery or bariatric surgery and died during surgery or after treatment.Footnote 26, Footnote 27 These outcomes raise troubling questions about professional judgment, technical skills, infection control, postoperative treatment, overall quality of care, and patient safety in some instances of medical travel. At present, although there is a global marketplace for health services, there are no assurances that treatment in various healthcare destinations meets an “international” standard of high-quality patient care. International accreditation of healthcare facilities might in time play a role in establishing global standards and practices. At present, however, it is unclear how effective international accreditation is in improving quality of care and promoting patient safety. International and intranational variations in quality of care remain a concern as increased numbers of patients enter the global health services marketplace.
Long-Distance Economy Air Travel, Surgery, and Risk of Thrombosis
Numerous publications examine the relationship between air travel and “economy-class syndrome.”Footnote 28, Footnote 29 Comparatively few articles consider how travel shortly before or after surgery might increase the risk of medical travelers experiencing thrombosis and pulmonary embolisms.Footnote 30 One case report identifies pulmonary embolism in a patient who traveled to the Dominican Republic for breast augmentation surgery and then, seventy-two hours later, flew home to Switzerland.Footnote 31 Another article describes fatal pulmonary embolism in a patient who traveled from Europe to a facility in the United States and died shortly after undergoing surgery.Footnote 32 Establishing in individual cases causal relationship rather than correlation between long-haul air travel and pulmonary embolism is problematic because blood clots can occur after surgery that is not preceded or followed by long-distance travel. While acknowledging this point, it is still possible to identify risk factors associated with combining surgical procedures with long-distance travel in cramped spaces.
No studies address whether individual medical travelers are routinely informed about the risks associated with combining long-distance air travel with surgery. If such risks are not disclosed to medical travelers, it is reasonable to question whether the healthcare providers are providing informed consent to all relevant risks associated with traveling long distances to obtain healthcare. Prophylactic use of anticoagulants and compression stockings can reduce the risk of thrombosis. Unfortunately, some medical travelers have surgery and shortly thereafter return home without being given medication and advice that might help them reduce the likelihood of thrombosis and pulmonary embolisms.
The Importance of Postoperative Care
Because they are focused on arranging timely and affordable medical procedures, some medical travelers might not fully appreciate the importance of having prompt access to proper postoperative care once they return to their local communities. When patients travel abroad for treatment, many of them undergo surgery or have other procedures and then return home within days or weeks. Without proper planning, communication, and coordination across distant healthcare settings, medical travel can pose serious challenges to the concept of a continuum of healthcare that extends from preoperative consultations to the act of surgery and from there to postoperative care, monitoring and treatment of infections and surgical complications, physical therapy and rehabilitation, and long-term follow-up care. By separating the act of surgery from preoperative care and postoperative treatment, it is possible that medical travel increases the risks faced by patients. The de-territorialization of healthcare, in which preoperative care, surgery, and postoperative care are fragmented across different geographic and institutional settings, risks undermining the quality and continuity of care and exposing patients to increased possibility of inadequate postoperative monitoring and treatment.
Integrating treatment provided by clinicians located in distant settings and domestic contexts is challenging because some physicians are reluctant to treat patients experiencing complications after receiving care from doctors based in other nations. Whether or not this is justified, some physicians in the United States, Canada, and elsewhere apparently fear becoming targets of lawsuits if they become involved in providing care to patients experiencing serious complications associated with receiving care at international medical facilities. It is possible to develop idealized models in which medical travelers go abroad, receive treatment, return home, and are treated by domestic healthcare providers in the event of complications. However, it is not clear that these accounts of globalized healthcare adequately capture the reluctance of some physicians to assume responsibility for treating serious complications that are the result of care provided by physicians in distant settings.
Liability and Medical Negligence
Difficulties obtaining adequate legal redress in instances in which patients are harmed while receiving care at international medical facilities constitute another problem with medical travel to some destinations. There is little likelihood of successfully suing for medical malpractice in some jurisdictions.Footnote 33 Although medical travelers who believe they have received medically negligent care might attempt to sue domestic medical tourism companies involved in facilitating medical care abroad, these businesses typically insist that their clients sign waiver of liability agreements specifying that medical tourism companies are not accountable for any harms occurring while their customers receive care at international facilities. These agreements are designed to serve as legal shields that will force patients to pursue legal action within the legal systems in the countries they visited for treatment.
Medical malpractice is typically conceived of as a legal concept. However, it is important to note the normative dimension to awarding patients damages when medical malpractice occurs and assigning responsibility when healthcare providers are found to have delivered treatment falling outside the scope of a professional standard of care. If medical travelers encounter reduced legal protections in some healthcare settings, possibilities for restitution after patients are harmed as a result of receiving care will be diminished. Efforts by medical tourism companies and some destination hospitals to avoid liability should be viewed through the lenses of both law and ethics.
Public Health, Health Systems, and Health Human Resources
The effects of medical travel on public health, public health systems, and health human resources require careful ethical analysis. Treating patients who experience complications after undergoing procedures abroad is costly for the publicly funded healthcare systems to which many medical travelers turn when they arrive home and require care. Physicians in one medical clinic in Alberta, Canada, reported that it cost their center $162,791 to treat ten patients experiencing complications after engaging in medical travel for bariatric surgery.Footnote 34 In documenting the case of a patient who traveled from Australia to India for a knee arthroplasty operation, Australian physicians indicated that providing antimicrobial therapy and four revision surgeries cost the Queensland health system more than $140,000 AUS.Footnote 35 They contrasted the cost of treating postoperative complications with the approximately $15,000 AUS it would have cost their public healthcare system if this patient had his knee replacement procedure performed in Australia. Additional case reports chronicle episodes in which individuals who had gone abroad for care returned home with complications requiring costly treatment provided by publicly funded healthcare systems.Footnote 36 In these cases, individual decisions to go abroad for inexpensive care resulted in significant expenditures for publicly funded health systems. In countries where patients do not have access to publicly funded postoperative care following medical travel, health insurers often will not cover the cost of treating complications resulting from healthcare obtained outside the medical facilities designated by health plans. Paying out of pocket to treat postoperative complications can be financially catastrophic for medical travelers. In short, expenses incurred by publicly funded health systems, private insurers, and individual patients all need to be taken into account when considering financial gains and losses flowing from increased transnational medical travel. At present, medical travel appears to generate a form of moral hazard in which private, for-profit medical tourism companies charge for facilitating treatment, and publicly funded healthcare systems in the communities to which medical travelers return must then bear the burden of providing publicly funded, medically necessary care for patients presenting with health problems requiring immediate treatment.
Medical Travel, Infectious Diseases, and Threats to Public Health
Transmission of infectious disease is another risk factor associated with medical travel. One report of an infectious disease outbreak involved a patient from England who traveled to India for a kidney transplant and returned with hepatitis B.Footnote 37 In this case, a nosocomial and community outbreak occurred, and eight additional individuals were infected with hepatitis B. Treating the patient, investigating the outbreak, and testing exposed individuals all consumed public resources. Medical travel, particularly as it becomes more commonplace, has implications for public health in addition to publicly funded health systems. The costs of treating disease outbreaks, much like the costs of treating individual cases of surgical complications, need to be incorporated into cost-benefit analyses of financial gains and losses flowing from globalization of healthcare and expanded trade in health services. At present, it appears that economic analyses of trade in health services emphasizes cost savings by comparing the prices of procedures in domestic settings with the cost of treatment at international medical destinations. These accounts do not adequately address the costs of providing postoperative care when complications emerge following treatment in international facilities. They also fail to address the costs associated with identifying, treating, addressing, and halting the transmission of infectious diseases.
Medical Travel and the Spread of Multidrug-Resistant Organisms
The spread of multidrug-resistant organisms is another risk factor associated with medical travel.Footnote 38, Footnote 39 There are now numerous reports of patients who have traveled to India and Pakistan for treatment and returned home with multidrug-resistant organisms containing the gene encoding New Delhi metallo B-lactamase 1 (NDM-1).Footnote 40 Global distribution of such drug-resistant organisms will have serious consequences for public health and publicly funded healthcare systems in countries around the world. To date, the costs associated with treating complex cases involving patients who are not responsive to standard antibiotics and halting the spread of multidrug-resistant organisms have not been taken into account when assessing economic gains and losses flowing from increased international trade in health services. More rigorous economic modeling of the financial consequences of medical travel needs to incorporate public health expenditures required to prevent further spread of multidrug-resistant organisms.
Health Human Resources and Access to Healthcare in Countries Attracting Medical Travelers
The effects of medical travel on public health and health human resources are not limited to the home communities to which patients return following treatment. Researchers examining the effects of medical tourism in India and Thailand argue that treating international patients draws healthcare providers from publicly funded health systems into private, for-profit healthcare facilities; promotes high-technology, interventionist types of healthcare at the expense of supporting primary care and preventive medicine; and results in a transfer of public resources to private, for-profit hospitals.Footnote 41, Footnote 42 Although some researchers suggest that treating international patients can enable cross-subsidized care of local individuals, there are numerous reports of health systems in which cross-subsidization has not occurred, despite assurances that “charity beds” would be made available to local citizens. Medical travel, when it occurs in sufficiently large numbers, can have deleterious consequences for public health, health systems, and health human resources in the home countries of medical travelers and the countries to which they journey for care.Footnote 43 There might be effective policy means and regulatory instruments that can be developed to mitigate and manage these harmful consequences. An important first step in addressing such problems is to better understand how attracting large numbers of international patients to particular healthcare settings can have unintended and undesired effects on destination health systems, public health infrastructure, and health human resources.
Conclusion
Transnational medical travel is the subject of extensive marketing efforts. The benefits of traveling for medical care are promoted by websites of destination healthcare facilities and medical tourism companies and by the national tourism websites of such countries as India, Malaysia, and Singapore. Less well-publicized are the many problems associated with traveling long distances, undergoing surgery, and returning home without plans for postoperative treatment. There are numerous reports of individuals who have undergone surgery abroad and then returned home with serious complications. News media accounts describe cases in which patients traveling abroad for cosmetic surgery or bariatric surgery died during or shortly after receiving medical care. These reports reveal the need for careful analysis of the risks and benefits of patients undergoing surgical procedures at medical facilities located far from their local healthcare providers. Scholars in bioethics and other areas of study can play an important role in helping prospective medical travelers, healthcare professionals, and policymakers address ethical issues, legal concerns, and questions about quality of care and patient safety. In particular, there is need for additional research examining the effects of increased medical travel on public health, health systems, and health human resources. “Medical tourism” is often described as a matter of individual consumer choice. Whether choices to go abroad benefit medical travelers—and clearly some medical travelers are harmed as a result of going abroad for treatment—the local communities to which they travel for treatment and the domestic healthcare facilities to which they must turn if complications occur abroad are affected by these “personal” choices to seek treatment at international medical facilities. Medical travel, in short, is not simply a matter of individual consumer choice but raises broad questions concerning public policy, public health, health human resources, and health equity.
Despite the numerous ethical, legal, and public health issues raised by medical travel, an increasing number of patients are crossing borders and seeking care far from home. With transnational medical travel receiving support from many constituencies—some that have direct financial interests in promoting medical travel and others that do not have economic interests but are ideologically supportive of increased international trade—it is by now nearly a matter of intellectual heresy to question the assumption that individual patients and national health systems will all benefit from greatly increased global trade in health services. As with many other convictions that are regarded as self-evident truths rather than justified on the basis of credible evidence, assumptions about individual, communal, and economic benefits flowing from increased transnational medical travel and globalization of health services require careful ethical analysis and rigorous empirical assessment.
